-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck Announces Positive Results for KEYTRUDA and Padcev Combination in Muscle-Invasive Bladder Cancer Study

路透·12/17/2025 11:45:25

登錄查看新聞詳情